Spoken Alpha · Executive
Sukumar Nagendran
President and Head of R&DatTSHATaysha Gene Therapies, Inc.Current
Tracked since Dec 30, 2022
Tracked across 14 earnings calls in our data since 2023.
Our data window: 2020–present. Actual tenure for some executives extends earlier — see company bio for full history.
Research tier
See how this executive's language deviates from their own baseline
Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.